Scientists at Weill Cornell Medicine in Qatar have created an intricate molecular map of the human body and its complex physiological processes based on the analysis of thousands of molecules in blood, urine and saliva samples from 391 volunteers.
A new book authored by researchers at the Tata-Cornell Institute for Agriculture and Nutrition (TCI) argues that India needs to rethink its social safety nets in order to address these issues and realize its full potential.
Neuroscientist Gary Gibson, Ph.D. ’73, keeps a framed picture of a cell derived from the skin cells of a person with Alzheimer’s disease on his office wall.
The image is a memento of Gibson’s breakthrough…
Ariel Avgar, is a professor in Cornell University’s school of Industrial and Labor Relations, where his research focuses on employment relations in the healthcare industry. He says setting mandatory staffing ratios is a great first step in making sure that residents receive high quality care, however, it should not be a standalone measure.
A classic psychedelic was found to activate a cell type in the brain of mice and rats that silences other neighboring neurons, providing insight into how such drugs reduce anxiety.
Cornell researchers have identified a switch that regulates inflammation caused by an immune response, a finding that could one day help to control inflammation-related conditions.
A study from Weill Cornell Medicine provides new insights into a pair of proteins and their opposing functions in regulating the interferon response in hepatic stellate cells, a critical immune component in the liver’s fight against tumors.
Researchers have identified the origin of ovarian cancer that develops in the fallopian tube, which opens doors to discovering new methods for diagnosing the disease and potential therapies.
A new study from Weill Cornell Medicine researchers helps explain why having ApoE4 – the gene variant most closely linked to Alzheimer’s disease – increases the risk of neurodegeneration and white matter damage.
